Managing treatment resistance in schizophrenia: a joint study in Hong Kong and Singapore

Managing treatment resistance in schizophrenia: a joint study in Hong Kong and Singapore

This study surveyed clinicians in psychiatry in Hong Kong and Singapore to understand their familiarity and prescribing practices in treatment-resistant schizophrenia (TRS) and clozapine-resistant schizophrenia (CRS).

Bibliographic Details
Main Authors:	Zheng, Shushan, Chan, Sherry Kit Wa, Lee, Jimmy
Other Authors:	Lee Kong Chian School of Medicine (LKCMedicine)
Format:	Journal Article
Language:	English
Published:	2023
Subjects:	Science::Medicine Clozapine Treatment Resistance
Online Access:	https://hdl.handle.net/10356/171024

Similar Items

Managing treatment resistance in schizophrenia: A joint study in Hong Kong and Singapore
by: Shushan Zheng, et al.
Published: (2022-10-01)

Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome
by: I. Kammoun, et al.
Published: (2022-06-01)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
by: Lally J, et al.
Published: (2016-11-01)

Treatment-resistant schizophrenia: How far have we traveled?
by: Ambu Pandey, et al.
Published: (2022-08-01)

Prescribing trends in treatment-resistant schizophrenia
by: Aynur Görmez, et al.
Published: (2017-10-01)

Prevalence of treatment resistant schizophrenia according to minima TRRIP criteria in a mental health catchment area in southern Spain
by: L.I. Muñoz-Manchado, et al.
Published: (2022-06-01)

Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?
by: H. Becerra Darriba
Published: (2021-04-01)

Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
by: Ming-Huan Zhu, et al.
Published: (2022-10-01)

Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review
by: Jiangbo Ying, et al.
Published: (2023-03-01)

Treatment resistance in schizophrenia: a meta-analysis of prevalence and correlates
by: Elton Diniz, et al.
Published: (2023-11-01)

Lurasidone Augmentation of Clozapine in Schizophrenia—Retrospective Chart Review
by: Marcin Siwek, et al.
Published: (2023-03-01)

Clozapine-Treatment-Resistant Schizophrenia Successfully Managed with Brexpiprazole Combination Therapy: Two Case Reports
by: L. Orsolini, et al.
Published: (2022-06-01)

Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
by: Jari Tiihonen, et al.
Published: (2012-01-01)

The usage of clozapine in a patient with schizophrenia and epilepsy: A case report
by: M. Karnickas, et al.
Published: (2021-04-01)

Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report
by: Maxine Yang, et al.
Published: (2023-06-01)

Resistant schizophrenia in a patient with oculocutaneous albinism successfully treated with clozapine
by: A. Jelti, et al.
Published: (2022-06-01)

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study
by: Norio Yasui‐Furukori, et al.
Published: (2022-03-01)

Does clozapine improve competency restoration? a case report of schizophrenia patient opined incompetent to stand trial unlikely to be restored
by: Aqeel Hashmi, et al.
Published: (2016-01-01)

Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
by: Vjekoslav Peitl, et al.
Published: (2023-04-01)

Differential effects of clozapine and risperidone on facial emotion recognition ability in patients with treatment-resistant schizophrenia
by: Gozde Gultekin, et al.
Published: (2017-01-01)

Editorial: Treatment resistance in psychotic disorders
by: Santanu Nath, et al.
Published: (2023-03-01)

Underuse of recommended treatments among people living with treatment-resistant psychosis
by: Julia M. Lappin, et al.
Published: (2022-09-01)

Clozapine combination and augmentation strategies in patients with schizophrenia - recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group
by: Wagner, Elias, et al.
Published: (2021)

Electroconvulsive therapy in a patient with resistant paranoid schizophrenia treated with clozapine
by: S. Castelao-Almodóvar, et al.
Published: (2021-04-01)

Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study [version 2; peer review: 1 approved, 2 approved with reservations]
by: Channaveerachari Naveen Kumar, et al.
Published: (2022-10-01)

Efficacy of clozapine for long‐stay patients with treatment‐resistant schizophrenia: 4‐year observational study
by: Kentaro Mizuno, et al.
Published: (2022-06-01)

Efficacy of clozapine in patients with schizophrenia – A 3-month follow-up study from North India
by: Paramvir Singh, et al.
Published: (2023-01-01)

Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study
by: Matsuzaki H, et al.
Published: (2023-03-01)

Combined use of antipsychotics and electroconvulsive therapy in theurapetically resistant schizophrenia
by: S. V. Sizov, et al.
Published: (2018-07-01)

Clozapine prescription trends in Brazil in the last decade
by: Raffael Massuda, et al.
Published: (2022-10-01)

A case study of the utilization of clozapine treatment for treatment‐resistant schizophrenia associated with 22q11.2 deletion syndrome
by: Arisa Tsurue, et al.
Published: (2023-06-01)

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia
by: Makoto Kinoshita, et al.
Published: (2017-03-01)

Augmentation strategies for treatment-refractory clozapine patients
by: O. Freudenreich
Published: (2021-04-01)

Prevalence of treatment resistance and clozapine use in early intervention services
by: Imogen Stokes, et al.
Published: (2020-09-01)

Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics
by: Sandeep Grover, et al.
Published: (2012-01-01)

The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
by: Licia Vellucci, et al.
Published: (2023-08-01)

Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study
by: Miquel Bioque, et al.
Published: (2020-01-01)

A case report—“When less is more”: controlled inpatient reduction of anticholinergic burden in a patient with clozapine-resistant schizophrenia
by: Milica Pjevac, et al.
Published: (2023-07-01)

Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder
by: Paria Hebrani, et al.
Published: (2015-01-01)

Clozapine use for bipolar disorder: an Asian psychotropic prescription patterns consortium study
by: Loo, Javier Lek Wei, et al.
Published: (2023)